Visceral Fat: Why Belly Fat Matters More Than Weight | YEARS

For decades, the public health debate has focused on weight and Body Mass Index (BMI). But these numbers only tell half the story. You can have a "normal" BMI and still carry a high metabolic risk. The crucial factor that often goes unnoticed is visceral fat.

It is the fat you cannot pinch. It wraps itself deep inside your abdominal cavity around your liver, intestines, and pancreas. Long misunderstood as a passive energy reserve, we now know that visceral fat is a highly active endocrine organ. It produces a cocktail of hormones and inflammatory messengers, quietly but steadily setting the stage for major lifestyle diseases.

This article explains the biology of visceral fat, why it is dangerous, how it can be precisely measured, and which evidence-based strategies actually help reduce it.

What Is Visceral Fat—and What Is It Not?

Not all fat is created equal. Medicine primarily distinguishes between two types of body fat:

1. Subcutaneous fat: This fat lies directly under the skin. You can pinch it on your belly, thighs, or buttocks. It serves as an energy reserve and insulation layer. Although an excess can also be problematic, subcutaneous fat is metabolically relatively harmless.
2. Visceral fat (intra-abdominal fat): This fat is located in the free abdominal cavity and envelops the internal organs. Do not think of it as a cushion, but rather as a biologically hyperactive roommate to your organs. It is directly connected to the portal vein, which transports blood from the digestive tract to the liver. This exact anatomical location explains its danger.

The main flaw of the BMI is that it distinguishes neither between fat types nor between muscle mass and bone mass. A muscular athlete can have a high BMI and be perfectly healthy. A slim person with low muscle mass but a high percentage of visceral fat can carry a massively elevated disease risk despite a normal BMI. In research, the term TOFI has been established for this phenomenon: "Thin Outside, Fat Inside."

From Passive Storage to Active Organ: The Pathophysiology of Visceral Fat

The paradigm shift in our understanding of adipose tissue is one of the most significant medical insights of recent decades. Visceral fat is not a passive mass. It is an endocrine organ that releases dozens of bioactive substances called adipokines. These molecules influence inflammatory processes, blood pressure, blood clotting, and insulin sensitivity throughout the body.

The Dangerous Messengers of Visceral Fat

An excess of visceral fat shifts the balance of adipokines in a harmful direction:

• Pro-inflammatory cytokines: Visceral fat produces large amounts of inflammatory promoters such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These substances create a state of chronic, low-grade inflammation, which is considered a breeding ground for atherosclerosis, insulin resistance, and certain types of cancer (Wellen & Hotamisligil, JCI 2003). The inflammatory marker hs-CRP (high-sensitivity C-reactive protein), which YEARS measures as a standard, can reflect this activity in the blood.
• Dysregulation of leptin and adiponectin:

* Leptin is the satiety hormone. With an excess of fat tissue, leptin levels rise, but the brain develops a resistance to it. As a result, you do not feel full despite having high energy reserves. Adiponectin improves insulin sensitivity and has an anti-inflammatory effect. However, visceral fat produces less* of it, which amplifies the negative effects (FET e.V.).

• Elevated free fatty acids: Visceral fat cells release free fatty acids into the bloodstream more easily than subcutaneous fat cells. Via the portal vein, these travel directly to the liver, where they disrupt sugar and fat metabolism, promote insulin resistance, and contribute to the development of non-alcoholic fatty liver disease (NAFLD).

The Direct Path to Insulin Resistance

The constant flood of free fatty acids from visceral fat overwhelms liver and muscle cells. To protect themselves from this toxic overload, the cells become less responsive to the hormone insulin. The pancreas must then produce more and more insulin to keep blood sugar levels stable. Eventually, it becomes exhausted. The HOMA-Index, a key marker in the YEARS Core® program, measures exactly this early stage of insulin resistance, long before fasting blood sugar rises.

The Consequences: Diseases Associated with Visceral Fat

The chronic inflammation and metabolic dysfunction originating from visceral fat create the foundation for a series of severe diseases:

1. Metabolic Syndrome: Not an independent disease, but a cluster of risk factors referred to in medicine as the "deadly quartet." According to the International Diabetes Federation (IDF) definition, it is present when an increased waist circumference is combined with at least two of the following four factors:

• Elevated triglyceride levels Low HDL cholesterol High blood pressure (hypertension) Elevated fasting blood sugar or diagnosed diabetes

1. Type 2 Diabetes: Insulin resistance is the direct consequence of excessive visceral fat and by far the most important modifiable risk factor for the development of type 2 diabetes.
2. Cardiovascular Diseases: Visceral fat drives the risk of heart attacks and strokes through multiple pathways: it promotes high blood pressure, worsens blood lipid profiles (dyslipidemia, precisely measured by ApoB), and accelerates atherosclerosis through chronic inflammation. The GEA study showed that a high visceral fat volume, measured by CT, was a strong predictor of recurrent cardiovascular events, even in patients who were well-managed with medication (Gamarra et al., JAHA 2021).
3. Non-alcoholic Fatty Liver Disease (NAFLD): The liver is the first organ to be flooded by free fatty acids from visceral fat. This leads to fat deposits in the liver cells, which can progress to liver inflammation (NASH) and eventually cirrhosis.
4. Dementia and Cognitive Decline: Chronic inflammatory processes and insulin resistance originating from visceral fat can damage the blood-brain barrier and promote neurodegenerative processes, increasing the risk of Alzheimer's and other forms of dementia (NDR, 2024).
5. Certain Cancers: Chronic inflammation and hormonal changes are associated with an increased risk of colon cancer, pancreatic cancer, and, in women, postmenopausal breast cancer.

Measuring Visceral Fat: From Tape Measures to Imaging

Because visceral fat is the decisive risk factor, its precise measurement is at the core of modern preventive medicine. There are various methods with differing levels of precision.

Level 1: The Tape Measure (Waist Circumference)

The simplest and most cost-effective method is measuring waist circumference. It is a surprisingly good, albeit indirect, indicator of the amount of visceral fat.

• Instructions: Place a tape measure horizontally around your abdomen at the level of your belly button, more precisely midway between your lowest rib and the top of your hip bone. Measure at the end of a normal exhalation without pulling your stomach in.
• IDF Cut-off Values:

* Men: From 94 cm (37 inches) increased risk, from 102 cm (40 inches) severely increased risk. * Women: From 80 cm (31.5 inches) increased risk, from 88 cm (34.6 inches) severely increased risk.

The tape measure is a good screening tool but cannot distinguish between subcutaneous and visceral fat.

Level 2: Bioelectrical Impedance Analysis (BIA) and 3D Body Scans

Professional BIA devices send a weak, imperceptible electrical current through the body. Because fat, water, and muscle conduct electricity differently, body composition—fat percentage, muscle mass, and water content—can be estimated. Many devices also provide an estimated value for visceral fat.

The 3D body scan in the YEARS Core® program creates a precise digital model of the body and calculates detailed circumference and volume measurements. These methods are more accurate than a tape measure but remain estimates that can be influenced by hydration status.

Level 3: Imaging Techniques (DXA, CT, MRI)

The gold standards for the exact quantification of visceral fat are imaging techniques.

• DXA Scan (Dual-Energy X-ray Absorptiometry): Originally developed for bone density measurement, DXA technology accurately divides body composition into fat mass, lean mass, and bone mass, providing a precise estimate of visceral fat.
• Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): These methods are the most accurate. They create detailed cross-sectional images of the abdomen, on which visceral fat is directly visible, distinguishable, and its volume exactly calculable. Because CT scans involve radiation exposure, whole-body MRI is preferred in comprehensive preventive diagnostics. It is a central component of the YEARS Evolve® program and provides a structural baseline of body composition that no other outpatient procedure achieves.

What You Can Do: Evidence-Based Strategies to Reduce Visceral Fat

Visceral fat often responds faster and better to lifestyle changes than stubborn subcutaneous fat.

1. Dietary Adjustments

No radical diets, but a sustainable adjustment of your eating habits aimed at reducing insulin spikes and inflammation.

• Reduce sugar and refined carbohydrates: Sugar, white flour products, and sweetened beverages lead to sharp insulin spikes. Insulin promotes fat storage, especially in the visceral area.
• Focus on fiber: Soluble fiber from oatmeal, legumes, apples, and flaxseeds improves insulin sensitivity and reduces fat absorption in the intestine.
• Integrate high-quality proteins: Protein-rich meals keep you full longer, which can lower overall calorie intake. Protein also increases the thermic effect of food.
• Favor unsaturated fats: Omega-3 fatty acids from fatty fish, flaxseeds, and walnuts have an anti-inflammatory effect and can help lower liver fat levels.
• Limit alcohol: Alcohol provides empty calories and is preferentially metabolized in the liver. This inhibits fat breakdown and promotes fat storage directly in the liver and abdominal cavity.

2. Targeted Exercise

Exercise is the most effective lever for breaking down visceral fat. A combination of endurance and strength training achieves the best results.

• Endurance training (Cardio): Moderate to intense training such as running, cycling, or swimming directly burns calories and mobilizes fat reserves. High-Intensity Interval Training (HIIT), featuring short, very intense phases with recovery periods in between, appears to be particularly effective.
• Strength training: Muscle mass increases your basal metabolic rate, meaning your body burns more energy even at rest. Muscles are also the largest "consumers" of blood sugar in the body. More muscle mass improves insulin sensitivity, thereby combating one of the central causes of visceral fat storage.

3. Sleep and Stress Management

Chronic sleep deprivation, defined as less than six to seven hours per night, measurably disrupts hormonal balance. Cortisol levels rise, the hunger hormone ghrelin increases, while the satiety hormone leptin decreases. The result: more cravings, a heightened stress response, and an increased tendency to store fat in the abdominal area.

Chronic psychological stress has the same effect. Permanently elevated cortisol specifically promotes the accumulation of visceral fat. Studies show that meditation, yoga, and regular exercise in nature can demonstrably lower cortisol levels.

A Complete Picture: How YEARS Measures Your Metabolic Risk

Knowing the danger of visceral fat is the first step. The second is precisely knowing your own status. A single measurement is not enough; YEARS creates a data-driven, comprehensive picture of your metabolic health.

In the YEARS Core® program, we combine several diagnostic pillars:

• Body composition: Bioelectrical Impedance Analysis (BIA) and a 3D body scan determine body fat percentage and provide precise circumference measurements that go far beyond the tape measure.
• Metabolic biomarkers: The HOMA-Index uncovers early-stage insulin resistance long before blood sugar rises. ApoB shows the actual number of atherogenic particles, mapping cardiovascular risk more accurately than classic LDL.
• Inflammatory markers: High-sensitivity C-reactive protein (hs-CRP) shows the level of chronic, low-grade inflammation, directly influenced by the activity of visceral fat.
• Organ imaging: An extended ultrasound of the liver and other abdominal organs makes a fatty liver or other structural changes visible at an early stage.

The YEARS Evolve® program adds whole-body MRI, which allows for the exact quantification of visceral and subcutaneous fat tissue and provides the most detailed foundation available for evaluating the internal organs.

In the concluding strategy session, the YEARS medical team brings all these data points together: body composition, biomarkers, and imaging results. This creates an individual risk profile and a concrete, prioritized plan.

Book your consultation now or compare our diagnostic programs.

---

Sources

• FET e.V. Fachgesellschaft für Ernährungstherapie und Prävention. Das Fettgewebe – ein hochaktives (endokrines) Organ. Abgerufen von fet-ev.de.
• Gamarra, P. F., D'Marco, L., et al. (2021). Visceral Adipose Tissue Is a Predictor of Recurrent Cardiovascular Events in Patients With Coronary Artery Disease. Journal of the American Heart Association (JAHA), 10(23), e022510. DOI: 10.1161/JAHA.121.022510.
• International Diabetes Federation (IDF). (2006). The IDF consensus worldwide definition of the metabolic syndrome. PDF.
• NDR Ratgeber. (2024). Bauchfett: Wie man das ungesunde viszerale Fett verliert. Abgerufen von ndr.de.
• Rosenfluh, F. (2007). Viszerales Fett als Risikofaktor für kardiovaskuläre Erkrankungen. Rosenfluh Publikationen AG. PDF.
• Wellen, K. E., & Hotamisligil, G. S. (2003). Obesity-induced inflammatory changes in adipose tissue. The Journal of Clinical Investigation (JCI), 112(12), 1785–1788. DOI: 10.1172/JCI20572.
• World Health Organization (WHO). (2011). Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva. ISBN 978-92-4-150149-1.